Author:
Fu Kaiyu,Li Qingli,Wang Jie,Zhang Mengpei,Yan Xinyu,Li Kemin,Song Liang,Zhong Lan,Ma Yu,Chen Jinghong,Zeng Jing,Wang Danqing,Shao Di,Zhu Shida,Yin Rutie
Abstract
AbstractDNA damage response (DDR) pathways are responsible for repairing endogenous or exogenous DNA damage to maintain the stability of the cellular genome, including homologous recombination repair (HRR) pathway, mismatch repair (MMR) pathway, etc. In ovarian cancer, current studies are focused on HRR genes, especially BRCA1/2, and the results show regional and population differences. To characterize germline mutations in DDR genes in ovarian cancer in Southwest China, 432 unselected ovarian cancer patients underwent multi-gene panel testing from October 2016 to October 2020. Overall, deleterious germline mutations in DDR genes were detected in 346 patients (80.1%), and in BRCA1/2 were detected in 126 patients (29.2%). The prevalence of deleterious germline mutations in BRCA2 is higher than in other studies (patients are mainly from Eastern China), and so is the mismatch repair genes. We identified three novel BRCA1/2 mutations, two of which probably deleterious (BRCA1 p.K1622* and BRCA2 p.L2987P). Furthermore, we pointed out that deleterious mutations of FNACD2 and RECQL4 are potential ovarian cancer susceptibility genes and may predispose carriers to ovarian cancer. In conclusion, our study highlights the necessity of comprehensive germline mutation detection of DNA damage response genes in ovarian cancer patients, which is conducive to patient management and genetic counseling.
Funder
the Science and Technology Department of Sichuan Province, Key R8D Program
the Key Project of Sichuan Provincial Department of Science and Technology
the project of Chengdu Science and Technology administration
Publisher
Springer Science and Business Media LLC